The Institute of Biochemistry II (IBC2) recruits new group leader: Dr. Manuel Kaulich will be leading the newly formed gene editing research group. Dr. Kaulich is an expert on cell cycle regulation and CRISPR-Cas9-rAAV gene replacement technologies.